… be promising for treating Parkinson’s disease in the future. Therefore, this review addresses
those cells in terms of their prospects in cell therapy for Parkinson’s disease. In addition, the …

… Cell-based therapies that involve transplantation into the striatum of dopaminergic cells
have attracted considerable interest as possible treatments for Parkinson's disease (PD). …

Parkinson's disease (PD) is one of the most common neurodegenerative disorders, which
affects about 0.3% of the general population. As the population in the developed world ages, …

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the degeneration
of dopaminergic neurons and/or loss od neuronal projections, in several dopaminergic …

… with Parkinson's disease in the early stages of the disease. However, once the “honeymoon”
period has waned, usually after a few years of dopaminergic therapy… in Parkinson's disease. …

… Pathophysiology of Parkinson disease: Factors influencing the development of … of novel
therapeutic approaches and challenges associated with the current anti-Parkinson drug therapy …

… In summary, a therapeutic intervention aimed at treating Parkinson's disease optimally
could have an effect lasting years, and be targeted to the nigrostriatal pathway, either through …

Parkinson’s disease (PD) is an incurable neurodegenerative condition of the central nervous
… This approach has now entered clinical trials and this review will analyse the therapeutic …

… while also reducing parkinsonian motor signs. To date, although several anti parkinsonian
therapeutics showed promise in providing neuroprotective therapy against this devastating …

… A variety of sources of dopaminergic cells have been investigated for treating PD in this way,
and in this review we discuss the basis of these, as well as their prospects for use in clinical …